Literature DB >> 18486311

GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.

Robin Ruszat1, Michael Seitz, Stephen F Wyler, Constanze Abe, Malte Rieken, Oliver Reich, Thomas C Gasser, Alexander Bachmann.   

Abstract

BACKGROUND: Long-term data of photoselective vaporization of the prostate (PVP) for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is scanty.
OBJECTIVE: Evaluate the long-term efficacy and the complication rate in 80-watt (W) PVP. DESIGN, SETTING, AND PARTICIPANTS: 500 consecutive patients with LUTS secondary to BPH underwent PVP between September 2002 and April 2007. The mean follow-up was 30.6+/-16.6 (5.2-60.6) mo. INTERVENTION: All patients underwent 80-W PVP performed by seven surgeons. MEASUREMENTS: We evaluated perioperative parameters, including operation time, delivered energy, changes of hemoglobin and serum sodium, catheterization, and hospitalization time as well as intraoperative and postoperative complications. Patients presenting for follow-up had data assessed on the International Prostate Symptom Score and quality-of-life questionnaire (IPPS-QoL), maximal flow rate (Q(max)), and post-voiding residual volume (Vres). RESULTS AND LIMITATIONS: Mean patient age was 71.4+/-9.6 (46-96) yr, with a mean preoperative prostate volume of 56.1+/-25.3 (10-180) ml. Mean operation time was 66.4+/-26.8 (10-160) min, and mean energy delivery was 206+/-94 (2.4-619.0) kJ. Despite ongoing oral anticoagulation in 45% of the patients (n=225), no severe intraoperative complications were observed. Mean catheterization and postoperative hospitalization time was 1.8+/-1.2 (0-10) and 3.7+/-2.9 (0-35) d, respectively. The mean IPSS after 3 yr was 8.0+/-6.2, the QoL score was 1.3+/-1.3, the Q(max) was 18.4+/-8.0 ml/s, and the Vres was 28+/-42 ml. The retreatment rate was 6.8%. Urethral and bladder neck strictures were observed in 4.4% and 3.6% of the patients, respectively. Localized prostate cancer was diagnosed during follow-up in six patients.
CONCLUSION: PVP is a safe and effective procedure for treatment of LUTS secondary to BPH. Patients on ongoing oral anticoagulation can be safely operated on. PVP leads to an immediate and sustained improvement of subjective and objective voiding parameters. The late complication rate is comparable to that of transurethral electroresection of the prostate.

Entities:  

Mesh:

Year:  2008        PMID: 18486311     DOI: 10.1016/j.eururo.2008.04.053

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  54 in total

1.  Endoscopic assessment and prediction of prostate urethral disintegration after histotripsy treatment in a canine model.

Authors:  George R Schade; Nicholas R Styn; Timothy L Hall; William W Roberts
Journal:  J Endourol       Date:  2011-11-08       Impact factor: 2.942

Review 2.  Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy.

Authors:  Julien Berger; Gregoire Robert; Aurelien Descazeaud
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

3.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

4.  Transurethral front-firing Greenlight bladder autoaugmentation for bladder contracture: technique and clinical outcomes.

Authors:  Ji-Ming Bao; Wan-Long Tan; Bing-Wei Wang; Xiao-Fu Qiu; Bai-Chuan Liu; Rui-Lun Zhong; Gao-Yuan Li; Guo-Sheng Yang
Journal:  Int Urol Nephrol       Date:  2016-01-23       Impact factor: 2.370

5.  Holmium laser transurethral incision of the prostate: Can prostate size predict the long-term outcome?

Authors:  Mohamed A Elkoushy; Ahmed M Elshal; Mostafa M Elhilali
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

6.  Five-year outcomes of thulium vapoenucleation of the prostate for symptomatic benign prostatic obstruction.

Authors:  A J Gross; A K Orywal; B Becker; C Netsch
Journal:  World J Urol       Date:  2017-04-12       Impact factor: 4.226

7.  Outcome analysis of transurethral resection versus potassium titanyl phosphate-photo selective vaporization of the prostate for the treatment of benign prostatic hyperplasia; a randomized controlled trial with 4 years follow up.

Authors:  Bimalesh Purkait; Rahul Janak Sinha; Krishna Swamy A Srinivas; Ankur Bansal; Ashok Kumar Sokhal; Vishwajeet Singh
Journal:  Turk J Urol       Date:  2017-04-18

8.  The volume of prostate can impact the male sexual function following photoselective vaporization of the prostate: results of a prospective analysis of 128 patients with 2-year follow-up.

Authors:  Zhen Guo; Xunbo Jin
Journal:  Int Urol Nephrol       Date:  2013-06-19       Impact factor: 2.370

9.  Urethral-sparing histotripsy of the prostate in a canine model.

Authors:  George R Schade; Timothy L Hall; William W Roberts
Journal:  Urology       Date:  2012-07-26       Impact factor: 2.649

Review 10.  Complications of laser prostatectomy: a review of recent data.

Authors:  Malte Rieken; Nicole Ebinger Mundorff; Gernot Bonkat; Stephen Wyler; Alexander Bachmann
Journal:  World J Urol       Date:  2010-01-06       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.